DRGEM Corporation (263690) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.051x

Based on the latest financial reports, DRGEM Corporation (263690) has a cash flow conversion efficiency ratio of 0.051x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.77 Billion ≈ $3.23 Million USD) by net assets (₩94.36 Billion ≈ $63.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of DRGEM Corporation to measure how much of total assets are equity-financed.

DRGEM Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how DRGEM Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of DRGEM Corporation to evaluate the quality of earnings relative to operating cash generation.

DRGEM Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DRGEM Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Revoil S.A AT:REVOIL	-0.040x
Optomed PLC HE:OPTOMED	-0.052x
Imago Mulia Persada Tbk PT JK:LFLO	0.093x
Vince Holding Corp NYSE:VNCE	0.085x
Brand 24 SA WAR:B24	0.338x
Nsys Co. Ltd. KQ:333620	0.014x
Asphere Innovations Public Company Limited BK:AS	0.054x
Actinium Pharmaceuticals Inc NYSE MKT:ATNM	-2.548x

Annual Cash Flow Conversion Efficiency for DRGEM Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of DRGEM Corporation from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 263690 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩92.11 Billion ≈ $62.42 Million	₩11.61 Billion ≈ $7.87 Million	0.126x	+197.19%
2024-12-31	₩86.65 Billion ≈ $58.72 Million	₩3.68 Billion ≈ $2.49 Million	0.042x	-77.56%
2023-12-31	₩79.32 Billion ≈ $53.75 Million	₩14.99 Billion ≈ $10.16 Million	0.189x	+89.35%
2022-12-31	₩73.63 Billion ≈ $49.90 Million	₩7.35 Billion ≈ $4.98 Million	0.100x	-41.37%
2021-12-31	₩61.01 Billion ≈ $41.34 Million	₩10.39 Billion ≈ $7.04 Million	0.170x	-11.38%
2020-12-31	₩52.53 Billion ≈ $35.60 Million	₩10.09 Billion ≈ $6.84 Million	0.192x	+109.64%
2019-12-31	₩32.52 Billion ≈ $22.04 Million	₩2.98 Billion ≈ $2.02 Million	0.092x	-12.35%
2018-12-31	₩28.68 Billion ≈ $19.43 Million	₩3.00 Billion ≈ $2.03 Million	0.105x	-31.41%
2017-12-31	₩15.65 Billion ≈ $10.61 Million	₩2.39 Billion ≈ $1.62 Million	0.152x	-67.90%
2016-12-31	₩9.54 Billion ≈ $6.46 Million	₩4.53 Billion ≈ $3.07 Million	0.475x	+196.20%
2015-12-31	₩7.93 Billion ≈ $5.37 Million	₩1.27 Billion ≈ $861.60K	0.160x	--

About DRGEM Corporation

KQ:263690 Korea Medical Devices

Market Cap

$37.07 Million

₩54.70 Billion KRW

Market Cap Rank

#22964 Global

#1481 in Korea

Share Price

₩5020.00

Change (1 day)

+2.03%

52-Week Range

₩4750.00 - ₩6510.00

All Time High

₩21390.25